MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Risk index and thrombolytic treatment in acute ischemic stroke--reply.
Risk index and thrombolytic treatment in acute ischemic stroke.
Districts' use of thrombolytic agents.
The risk of stroke after thrombolytic therapy.
The risk of stroke after thrombolytic therapy.
Thrombolytic, antiplatelet, and antithrombotic agents.
The usefulness of the Kurashiki prehospital stroke scale in identifying thrombolytic candidates in acute ischemic stroke.
Current concepts: guidelines for the use of thrombolytic agents.
Platelet function after in vivo and in vitro treatment with thrombolytic agents.
Use of thrombolytic agents to treat pulmonary embolism in pregnancy.
Domiciliary thrombolytic treatment.
A simple risk index and thrombolytic treatment response in acute ischemic stroke.
Domiciliary thrombolytic treatment.
Thrombolytic treatment of pulmonary embolism.
Development of new thrombolytic agents using recombinant DNA technology.
Influence of thrombolytic agents on human platelet function.
Temperature-sensitive liposome-mediated delivery of thrombolytic agents.
Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
Implementing thrombolytic guidelines in stroke care: perceived facilitators and barriers.
Thrombolytic treatment for elderly patients.
Progress in Intravenous Thrombolytic Therapy for Acute Stroke.
Repeated thrombolytic therapy in patients with recurrent acute ischemic stroke.
Thrombolytic intervention in acute thrombotic and embolic stroke.
Process improvement to enhance existing stroke team activity toward more timely thrombolytic treatment.
Thrombolytic agents in the treatment of stroke.
Thrombolytic agents in the treatment of stroke. - PDF Download Free
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Risk index and thrombolytic treatment in acute ischemic stroke--reply.
Risk index and thrombolytic treatment in acute ischemic stroke.
Districts' use of thrombolytic agents.
The risk of stroke after thrombolytic therapy.
The risk of stroke after thrombolytic therapy.
Thrombolytic, antiplatelet, and antithrombotic agents.
The usefulness of the Kurashiki prehospital stroke scale in identifying thrombolytic candidates in acute ischemic stroke.
Current concepts: guidelines for the use of thrombolytic agents.
Platelet function after in vivo and in vitro treatment with thrombolytic agents.
Use of thrombolytic agents to treat pulmonary embolism in pregnancy.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
